Rafina Innovations Inc (VICA)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Rafina Innovations Research and Development Expense (Quarterly): 0.0589M for March 31, 2019
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2019 | 0.0589M |
| December 31, 2018 | 0.0757M |
| September 30, 2018 | 0.0189M |
| June 30, 2018 | 0.1007M |
| March 31, 2018 | 0.0833M |
| December 31, 2017 | 1.068M |
| September 30, 2017 | 0.0496M |
| June 30, 2017 | 0.0945M |
| March 31, 2017 | 0.0781M |
| December 31, 2016 | 0.0611M |
| September 30, 2016 | 0.0757M |
| June 30, 2016 | 0.0768M |
| March 31, 2016 | 0.1271M |
| Date | Value |
|---|---|
| December 31, 2015 | 0.123M |
| September 30, 2015 | 0.0723M |
| June 30, 2015 | 4.739M |
| March 31, 2015 | 0.3836M |
| December 31, 2014 | 0.3325M |
| September 30, 2014 | 0.3544M |
| June 30, 2014 | 1.333M |
| March 31, 2014 | 0.6322M |
| December 31, 2013 | 0.0027M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Medite Cancer Diagnostics Inc | 0.142M |
| SheerVision Inc | -- |
| Sunridge International Inc | -- |
| Perspective Therapeutics Inc | 7.452M |
| Xtant Medical Holdings Inc | 0.527M |